Hypoglycemia is fatal if associated with sepsis in endstage renal disease (ESRD) patients. We report a hemodialysis patient of streptococcal toxic shock syndrome presenting with hypoglycemia. She was found to be severely hypoglycemic with a plasma glucose level of 16 mg/dl. Immunoreactive insulin levels were undetectable throughout the clinical course. Several factors including reduced renal gluconeogenesis, reduced hepatic glucose output and excessive peripheral glucose utilization mayaccount for the hypoglycemia in this patient. In conclusion, we would like to draw attention to the fact that septic ESRDpatients without diabetes are prone to develop profound hypoglycemia with serious consequences.
Introduction
Hypoglycemia frequently occurs in end-stage renal disease (ESRD) patients, and it is fatal if associated with either sepsis or malnutrition (1) . Glucose metabolism is routinely considered to be disordered in ESRDpatients (2) . The various postulated mechanisms underlying disordered glucose metabolism in ESRDare intriguing (3) (4) (5) . The outcome for hypoglycemic septic ESRDpatients is ominous. Here, we report a hemodialysis patient of streptococcal toxic shock syndrome (STSS) presenting with spontaneous hypoglycemia with special emphasis on its pathophysiological mechanisms.
Case Report
A 77-year-old womanreferred to our hospital with sudden onset of intractable lumbago and severe pain in the left thigh in June 28, 2000. The patient had been on maintenance hemodialysis (HD) for 10 years. Diabetes mellitus causing chronic renal failure had not been identified. On physical examination, the temperature was 36.0°C, respiratory rate was, 28 breaths per minute, the pulse was 108 beats per minute, the blood pressure was <60 mmHg,body height was 150.0 cm, body weight was 47 kg, body mass index was 21 kg/m2, and mental status was drowsy. Her left thigh was erythematous and swollen. Initial laboratory findings are shown in Table 1 . Serum albumin level was 2.6 g/dl and cholesterol level was 64 mg/dl, thus the patient was malnourished. The patient was a hepatitis C carrier. Arterial blood gases showed pH of 7.268, pCO2 of 31.2 mmHg, pO2 of 68.5 mmHg, HCO3" 13.8 mEq/Z, and base excess (BE) of -ll.7 mEq/Z on room air.
Bacterial tonsillar, urinary, and blood cultures were positive for streptococcus pyogenes and the patient fulfilled all the proposed criteria for Streptococcal toxic shock syndrome (STSS) (6). Immediate intravenous antibiotic therapy (imipenem/cilastatin; IPM/CS at a daily dose of 2 g and sultamicillin; ABPC/SBTat a daily dose of 12 g) and intravenous immunoglobulin (IVIG) at a daily dose of 5 g were initiated. Despite the initial appropriate therapy with dopamine at a dose of 5 |ug/min and methyl-prednisolone (m-PSL) at a dose of 500 mg, hemodynamic instability continu- 
Discussion
Sepsis alters both whole-body and tissue glucose disposal (7, 8) . However, the magnitude and even the directional change of the glucose metabolic response can be influenced by the severity of the insult or the time point examined. Hyperglycemiais a common manifestation of the acute early host response. This response appears to result from any of the following abnormalities: 1) stimulation of both hepatic glycogenolysis and gluconeogenesis by sepsis-induced stress hormones (glucagons, corticosterone, and epinephrine); 2) augmented renal gluconeogenesis.
Increased production of glucose in this situation transiently exceeds the rate of glucose disposal by peripheral tissues, resulting in the observed hyperglycemia. Under relatively severe septic conditions, the rate of glucose use exceeds the rate of glucose production, resulting in hypoglycemia. Sepsis was responsible for 66% of all mortalities in ESRDpatients presenting with hypoglycemia (7).
Several factors may account for hypoglycemia in this hemodialysis patient. One contributing factor may be reduced renal gluconeogenesis.
Normally, hepatic glycogenolysis, and to a lesser extent, hepatic gluconeogenesis, account for the majority of glucose supply, while glucose consumption is primarily determined by insulin levels. However, in insulin-deficient states, renal gluconeogenesis is induced. Surprisingly, despite its inferiority relative to the liver in total glucose production, the renal cortex actually outperforms the liver in gluconeogenesis, if compared on a gramfor-gram basis (9-12). Thus, the role of renal glucose production is more substantial and its cessation maylead to hypoglycemia because the insulin level was not detectable throughout the clinical course in this septic ESRDpatient. A secondary contributing factor playing a role in the duration and severity of hypoglycemia in this patient may include the simultaneous presence of malnutrition and concomitant liver disease which led to reduced hepatic glucose output.
Wehave hypothesized that the capacity for hormonestimulated glycogenolysis and gluconeogenesis is markedly depressed in cirrhotic and acute exacerbated hepatocytes for any given level of substrate delivery and sympathohormonal tone. Under critically ill conditions, hepatic glycogen reserves may be largely depleted and acidosis suppresses hepatic glucose production via glycogenolysis. Additionally, sepsis is associated with a rapid decrease in the expression of genes that encode transcription of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), two important enzymes in the gluconeogenic pathway (13, 14).
The third contributing factor may be excessive peripheral glucose utilization in the septic state (7). In general, glucose disposal results via either insulin-or noninsulin-mediated glucose uptake or these two pathways appear to be regulated independently. The ability of the physiological concentration of insulin to stimulate glucose uptake primarily involves insulin-sensitive tissues. Hence, sepsis-induced changes in circulating insulin levels might be expected to modulate glucose uptake in striated muscle and adipose tissue. In con- Hypoglycemia in a Septic Hemodialysis Patient trast, noninsulin-mediated glucose uptake occurs to varying degrees in all tissues and is responsible for most glucose uptake under postabsorptive conditions. In this patient, noninsulin-mediated glucose uptake might have been excessive because of the septic and insulin-deficient state. In addition, the inflammatory cytokine TNFa can also increase noninsulin-mediated glucose uptake in several tissues inde- 
